UCLA Health

The Luskin Orthopaedic Institute for Children Announces $50 Million Estate Gift by Meyer & Renee Luskin at Annual Stand for Kids Gala

Retrieved on: 
火曜日, 6月 11, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240611430067/en/
    Meyer & Renee Luskin with Michael Sullivan, LuskinOIC VP; Craig Ehrlich, LuskinOIC Board Chair; and Michael Buffer after $50 million Estate Gift announcement at the LuskinOIC Stand for Kids Gala at SoFi Stadium.
  • Photo credit Presley Ann, Getty Images
    Supporters enjoyed an exclusive night of excitement and goodwill on the 50-yard line of SoFi Stadium .
  • What makes LuskinOIC unique is their focus on caring for underserved kids; 85% of their children are underinsured and 75% are children of color.
  • The band performed rock classics such as “Don’t Stop Believin’,” “Black Magic Woman,” “Oye Como Va,” and more.

Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala Benefits Advancing Health Equity for Every Child in Los Angeles and Beyond

Retrieved on: 
木曜日, 6月 6, 2024

The Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala , on Saturday, June 8, 2024 will benefit LuskinOIC’s mission of advancing health equity for every child in Los Angeles and beyond.

Key Points: 
  • The Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala , on Saturday, June 8, 2024 will benefit LuskinOIC’s mission of advancing health equity for every child in Los Angeles and beyond.
  • LuskinOIC has been instrumental in enhancing sports medicine, particularly in pediatric orthopaedics, through innovative treatments and dedicated research.
  • The Los Angeles Chargers will receive the Community Inspiration Award and Students Run LA will receive the Power of Partnership Award on the 50-yard line of SoFi Stadium .
  • Wear your favorite team colors to the '50 Yard Line Fancy' cocktail gala, which runs from 6pm – 11pm.

Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important

Retrieved on: 
火曜日, 5月 21, 2024

The sports nutrition market is experiencing robust growth due to increasing consumer awareness about the importance of fitness and healthy lifestyles.

Key Points: 
  • The sports nutrition market is experiencing robust growth due to increasing consumer awareness about the importance of fitness and healthy lifestyles.
  • Key growth drivers include a surge in health-conscious consumers, a growing fitness culture, and a rising interest in sports activities.
  • The surge in demand for protein powder in the sports nutrition market is attributed to its versatile and convenient nature.
  • As a vital component for muscle repair and growth, protein powder caters to the increasing fitness consciousness among consumers.

Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala Honors the Los Angeles Chargers and Students Run LA on the 50-yard Line of SoFi Stadium on June 8, 2024

Retrieved on: 
木曜日, 5月 23, 2024

The Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala will honor the Los Angeles Chargers with the Community Inspiration Award and Students Run LA with the Power of Partnership Award on the 50-yard line of SoFi Stadium on Saturday, June 8, 2024.

Key Points: 
  • The Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala will honor the Los Angeles Chargers with the Community Inspiration Award and Students Run LA with the Power of Partnership Award on the 50-yard line of SoFi Stadium on Saturday, June 8, 2024.
  • The Stand for Kids Gala will benefit LuskinOIC’s mission of advancing health equity for every child in Los Angeles and beyond.
  • LuskinOIC has been instrumental in enhancing sports medicine, particularly in pediatric orthopaedics, through innovative treatments and dedicated research.
  • Join us on the 50-yard line at SoFi Stadium as we celebrate LuskinOIC’s long history of keeping our children healthy and active!

New Study Demonstrates Avenda Health's Unfold AI to Better Predict Focal Therapy Success by 77% Percent as Compared to Standard Methods

Retrieved on: 
水曜日, 5月 8, 2024

CULVER CITY, Calif., May 8, 2024 /PRNewswire/ -- Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils the results of a new UCLA study examining the role of AI in identifying tumor margins and predicting the efficacy of focal therapy treatments. The study titled "Software to Determine Extent of Tumor Margins in Focal Therapy," was presented at the 2024 American Urological Association's (AUA) annual meeting by Wayne Brisbane, MD, assistant professor at UCLA Health. It demonstrated that Unfold AI, Avenda Health's AI-powered cancer mapping technology, was a better predictor of focal therapy success than other factors, including the size or grade of the tumor.

Key Points: 
  • It demonstrated that Unfold AI , Avenda Health's AI-powered cancer mapping technology, was a better predictor of focal therapy success than other factors, including the size or grade of the tumor.
  • In the study, FDA-cleared Unfold AI technology was retrospectively applied to 118 previously untreated men undergoing hemi-gland cryotherapy for prostate cancer ablation.
  • MRI-guided biopsies, both targeted and systematic, were performed before cryotherapy and six months after cryotherapy to assess treatment outcomes.
  • "This more comprehensive approach enhances our ability to predict treatment outcomes and tailor interventions effectively to individual patient needs."

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias

Retrieved on: 
水曜日, 5月 8, 2024

AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024.

Key Points: 
  • AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024.
  • Participants included practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex cardiac arrhythmias—a condition in which the heart beats with an irregular or abnormal rhythm.
  • The primary teaching tool was live cases with expert commentary broadcast from the Electrophysiology Center at St. David's Medical Center, the leading robotic electrophysiology center in North America.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/texas-cardiac-arrhythmia-instit...
    SOURCE Texas Cardiac Arrhythmia Institute at St. David’s Medical Center

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias

Retrieved on: 
水曜日, 5月 8, 2024

AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024.

Key Points: 
  • AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024.
  • Participants included practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex cardiac arrhythmias—a condition in which the heart beats with an irregular or abnormal rhythm.
  • The primary teaching tool was live cases with expert commentary broadcast from the Electrophysiology Center at St. David's Medical Center, the leading robotic electrophysiology center in North America.
  • Physicians received a maximum of 14.5 American Medical Association (AMA) Physician's Recognition Award (PRA) Category 1 Credit™ hours at the conference.

Studies Find Disparities in Urologic Cancer Diagnosis and Care for Black Americans

Retrieved on: 
金曜日, 5月 3, 2024

Researchers will present their study findings covering disparities and urologic cancer in San Antonio, TX, from May 3 to 6.

Key Points: 
  • Researchers will present their study findings covering disparities and urologic cancer in San Antonio, TX, from May 3 to 6.
  • Adam Weiner, MD, urologist at UCLA Health, moderated a virtual press session with the abstract authors, providing key insights into their research.
  • “These abstracts stood out in terms of relevance and potential impact for the urology field,” said Dr. Weiner.
  • “We have examples of ecological studies, retrospective cohort studies, and qualitative studies that all aim to highlight and address disparities in urological cancer outcomes.”
    The following abstracts are covered in the moderated panel:

The 22nd Annual OneLegacy Run/Walk Closes Donate Life Month Celebrations Gathering Thousands of Donor Families, Grateful Recipients and Donation Advocates at Azusa Pacific University to Honor the Gift of Life

Retrieved on: 
木曜日, 5月 2, 2024

More than 200 teams and over 20 exhibitors participated in this special event, which marked the culmination of Donate Life month.

Key Points: 
  • More than 200 teams and over 20 exhibitors participated in this special event, which marked the culmination of Donate Life month.
  • View the full release here: https://www.businesswire.com/news/home/20240502456947/en/
    Nearly 4,000 deceased donor families, transplant recipients and donation advocates gathered last Saturday, April 27 at Azusa Pacific University to celebrate the 22nd Annual OneLegacy Donate Life Run/Walk.
  • Assemblymember Blanca Rubio, Azusa Mayor Robert Gonzales and Donate Life California’s CEO, Jim Martin, shared special remarks during the opening ceremony.
  • All proceeds from the 22nd Annual OneLegacy Donate Life Run/Walk will benefit the OneLegacy Foundation’s public education programs, with the goal of inspiring local communities to donate life.

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update

Retrieved on: 
水曜日, 3月 27, 2024

BOSTON, March 27, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2023.
  • Gamida Cell will become a private company, wholly owned by Highbridge, and the company’s outstanding ordinary shares are expected to be canceled.
  • The company has confirmed coverage with payers who cover more than 90% of commercial lives, exceeding the 2023 goal of 70%.
  • The full year Net Revenue included $1.1 million of net review for the fourth quarter of 2023.